GILEAD Stock Analysis Update! Is REMDESIVIR The Vacine Cure? (GILD)

Today Gilead Science stock shares increased significant gains after reports US health authorities are reportedly preparing to allow emergency use of Gilead's antiviral Remdesivir to treat patients, following positive study results. The results showed that patients symptoms improved. I will go in-depth in the stock analysis and if its a good buy and if its a good dividend stock.

🚀 Robinhood (1 free stock) - https://join.robinhood.com/ducl44
🚀 Webull (2 free stocks)- https://tinyurl.com/vprdw3b
🚀 M1 Finance (free $10 sign up) - https://m1.finance/QWhSeXftBRUi
✅Personal Capital (track your finance) - https://tinyurl.com/yd22k8mq
✅My Capital One Savings Account - https://tinyurl.com/y74se35x

Social Media:
Main channel - https://www.youtube.com/nukemdukem
My Finance Facebook Page - https://www.facebook.com/nukemfinance
Twitter - https://twitter.com/NukemDukemz
Instagram - https://www.instagram.com/nukemdukemz/

#gild #gildstock #remdesivir

Видео GILEAD Stock Analysis Update! Is REMDESIVIR The Vacine Cure? (GILD) канала Nukem Finance